Hepatitis C Treatment in Probation and Parole Office

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

77 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-08-23

Study Completion Date

2024-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective cohort study compares aims to determine the efficacy and effectiveness of telemedicine-supported on-site linkage to care and treatment in a community probation and parole office (P\&P office) setting and compare the results with a historic control with referral to care. Research participants will be followed in the P\&P office when they report to their officer during regularly scheduled appointments. Participants will receive treatment without having to travel to a specialist's office. The telemedicine visit will include a consultation with an experienced HCV provider such as a hepatologist or an advanced practice provider and a specialty pharmacist who will educate about and monitor HCV treatment. The UK specialty pharmacy will be available to participants and the HCV management team through a 24-hour support line. Participants will be treated per HCV guidelines and insurance preference.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

UCLA-Amity Parolee Health Promotion Study

NCT01844414

Hepatitis B Hepatitis C HIV +1 more

COMPLETED NA

Effective Treatment of Hepatitis C in Substance Users

NCT00633243

Hepatitis C Opiate Dependence

COMPLETED NA

Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1

NCT00142935

HIV Prevention Opioid-Related Disorders

COMPLETED NA

Patient-Centered Care for Opioid Use Disorders in Federally Qualified Healthcare Centers and Specialty Care Settings

NCT03367234

Opioid-use Disorder Substance Use Disorders

WITHDRAWN NA

A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail

NCT02334215

Opioid Use Disorder

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatitis C HCV

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants with Hepatitis C

Participants will be clients at the Lexington Probation and Parole office who are Hepatitic C positive.

Group Type EXPERIMENTAL

Telehealth in Parole/Probation Office

Intervention Type BEHAVIORAL

Onsite (telehealth) linkage toHep C treatment in a Probation and Parole office setting via an onsite nurse navigator. The navigator will provide Hep C education, draw labs, and facilitate a telemed visit with a UK GI provider.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telehealth in Parole/Probation Office

Onsite (telehealth) linkage toHep C treatment in a Probation and Parole office setting via an onsite nurse navigator. The navigator will provide Hep C education, draw labs, and facilitate a telemed visit with a UK GI provider.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clients who will be supervised in the probation and parole office for at least 5 months
* History of hepatitis C
* Able to obtain health insurance
* Capacity to provide written, informed consent
* Life expectancy \>1 year

Exclusion Criteria

* Negative HCV RNA
* Pregnant or breast-feeding
* HIV or HBV co-infection
* Liver cirrhosis with Child-Turcotte-Pugh score 6 or greater at baseline lab work
* Subjects with impaired capacity to provide informed consent

Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No